What’s New
Posted on Monday, March 28, 2022
Just five days after the World Health Organization (WHO) classified B.1.1.529 as a variant of concern (VOC), scientists in San Francisco identified the first case of Omicron in the United States. The Infectious Disease Division at the University of California, San Francisco (UCSF), received funding from CDC to track the evolution and spread of SARS-CoV-2 in the state. Supplemental support to state, local, and territorial public health laboratories and strategic investments in academic research projects have expanded the reach of genomic sequencing.
Posted on Friday, March 18, 2022
CDC announced a new competitive cooperative agreement on March 18, 2022, that will provide funding to establish the US Pathogen Genomics Centers of Excellence (PGCoE) network. This cooperative agreement will establish several centers of excellence, each consisting of a health department and one or more academic institutions.
Posted on Friday, March 11, 2022
In a recent episode of the Emerging Infectious Diseases podcast, host Sarah Gregory spoke with Dr. Jorge Muñoz-Jordan, Lead for NCEZID’s Dengue Diagnostics and Research Laboratory Team. They discussed the origin, spread, and evolution of the Zika virus in Puerto Rico from 2016 through 2017 and how the availability of next-generation sequencing helped them learn more about this virus. Dr. Muñoz also spoke about how the team was able to build on their existing work with vector-borne diseases to develop a molecular diagnostic test for Zika.
Posted on Wednesday, January 26, 2022
The Advanced Molecular Detection (AMD) program is helping build and integrate laboratory, bioinformatics, and epidemiology technologies across CDC and nationwide. The new AMD Investments section features a set of three national maps that detail how the AMD program supports state and local jurisdictions to build genomic sequencing capacity and provide workforce training. The maps represent funding from annual AMD appropriations and other supplemental sources, including multi-year funding from the American Rescue Plan Act of 2021. This support is distributed through the ELC and other funding mechanisms.